Functional requirement for the SE in maintenance of MLL-AF9 driven murine AML has recently been demonstrated19 and we confirmed using CRISPR/Cas9 interference of the SE that this requirement extends to human MLL-AF9-driven AML. This evidence concerns the gene KMT2A and acute myeloid leukemia.